- Home
- PHAR vs EXOD Comparison
PHAR vs EXOD Comparison
Compare PHAR & EXOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- EXOD
- Stock Information
- Founded
- PHAR 1988
- EXOD 2015
- Country
- PHAR Netherlands
- EXOD United States
- Employees
- PHAR N/A
- EXOD N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- EXOD
- Sector
- PHAR Health Care
- EXOD
- Exchange
- PHAR Nasdaq
- EXOD NYSE
- Market Cap
- PHAR 718.1M
- EXOD 765.3M
- IPO Year
- PHAR N/A
- EXOD N/A
- Fundamental
- Price
- PHAR $10.45
- EXOD $31.87
- Analyst Decision
- PHAR Strong Buy
- EXOD Strong Buy
- Analyst Count
- PHAR 3
- EXOD 3
- Target Price
- PHAR $30.00
- EXOD $64.33
- AVG Volume (30 Days)
- PHAR 2.6K
- EXOD 174.4K
- Earning Date
- PHAR 07-31-2025
- EXOD 08-12-2025
- Dividend Yield
- PHAR N/A
- EXOD N/A
- EPS Growth
- PHAR N/A
- EXOD N/A
- EPS
- PHAR N/A
- EXOD 1.44
- Revenue
- PHAR $320,708,000.00
- EXOD $123,208,000.00
- Revenue This Year
- PHAR $13.31
- EXOD $32.58
- Revenue Next Year
- PHAR $7.68
- EXOD $27.75
- P/E Ratio
- PHAR N/A
- EXOD $22.45
- Revenue Growth
- PHAR 24.13
- EXOD 71.36
- 52 Week Low
- PHAR $6.65
- EXOD $12.02
- 52 Week High
- PHAR $12.61
- EXOD $117.40
- Technical
- Relative Strength Index (RSI)
- PHAR 47.51
- EXOD N/A
- Support Level
- PHAR $10.41
- EXOD N/A
- Resistance Level
- PHAR $11.50
- EXOD N/A
- Average True Range (ATR)
- PHAR 0.32
- EXOD 0.00
- MACD
- PHAR -0.17
- EXOD 0.00
- Stochastic Oscillator
- PHAR 2.26
- EXOD 0.00
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About EXOD EXODUS MOVEMENT INC
Exodus Movement Inc is a self-custodial platform that connects people with the world of decentralized finance and the power of the blockchain. Available for desktop and mobile, it allows users to secure, manage and exchange cryptocurrencies like Bitcoin, Ethereum. Geographical presence in Europe, United States, the Middle East, and Africa (EMEA); Asia-Pacific (APAC); and Canada and Latin America (Other Americas).